Next Article in Journal
Copolymers of 4-Trimethylsilyl Diphenyl Acetylene and 1-Trimethylsilyl-1-Propyne: Polymer Synthesis and Luminescent Property Adjustment
Next Article in Special Issue
Comparison of the Content of Extractives in the Bark of the Trunk and the Bark of the Branches of Silver Fir (Abies alba Mill.)
Previous Article in Journal
Discovery of Hepatotoxic Equivalent Markers and Mechanism of Polygonum multiflorum Thunb. by Metabolomics Coupled with Molecular Docking
Previous Article in Special Issue
Bioactivity Guided Study for the Isolation and Identification of Antidiabetic Compounds from Edible Seaweed—Ulva reticulata
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Molecules
Volume 28
Issue 1
10.3390/molecules28010026
molecules-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Phytochemical Characterization, Antioxidant and Anti-Inflammatory Effects of Cleome arabica L. Fruits Extract against Formalin Induced Chronic Inflammation in Female Wistar Rat: Biochemical, Histological, and In Silico Studies

by
Ikram Allagui
1,2,
Mabrouk Horchani
3,
Nourhene Zammel
4,
Maroua Jalouli
5,
Abdelfatteh Elfeki
1,
Choumous Kallel
6,
Lamjed Mansour
7,
Salah Alwasel
7,
Abdel Halim Harrath
7,*,
Hichem Ben Jannet
3,
Mohamed Salah Allagui
1,2 and
Kheiria Hcini
8,9,*
1
Laboratory of Animal Physiology, Faculty of Sciences of Sfax, University of Sfax, P.O. Box 95, Sfax 3052, Tunisia
2
Laboratory of Biotechnology and Biomonitoring of the Environment and Oasis Ecosystems, Faculty of Sciences of Gafsa, University Campus Sidi Ahmed Zarroug, University of Gafsa, Gafsa 2112, Tunisia
3
Laboratory of Heterocyclic Chemistry, Natural Products and Reactivity (LR11Es39), Medicinal Chemistry and Natural Products, Faculty of Science of Monastir, University of Monastir, Avenue of Environment, Monastir 5000, Tunisia
4
Laboratory of Histo-Embryology and Cytogenetics, Medicine Faculty of Sfax, University of Sfax, Sfax 3029, Tunisia
5
Department of Biology, College of Science, Imam Mohammad Ibn Saud Islamic University (IMSIU), Riyadh 11623, Saudi Arabia
6
Laboratory of Hematology, University of Sfax, CHU Habib Bourguiba, Sfax 3029, Tunisia
7
Department of Zoology, College of Science, King Saud University, Riyadh 11451, Saudi Arabia
8
Biodiversity, Biotechnology and Climate Change Laboratory (LR11ES09), Department of Life Sciences, Faculty of Science of Tunis, University of Tunis El Manar, Tunis 2092, Tunisia
9
Department of Life Sciences, Faculty of Sciences of Gafsa, University Campus Sidi Ahmed Zarroug, University of Gafsa, Gafsa 2112, Tunisia
*
Authors to whom correspondence should be addressed.
Molecules 2023, 28(1), 26; https://doi.org/10.3390/molecules28010026
Submission received: 17 October 2022 / Revised: 23 November 2022 / Accepted: 17 December 2022 / Published: 21 December 2022
(This article belongs to the Special Issue Extraction, Identification and Isolation of Chemical Compounds in Natural Matrices)
Browse Figures
Review Reports Versions Notes

Abstract

:
In recent decades, the use of herbs and plants has been of great interest, as they have been the sources of natural products, commonly named as bioactive compounds. In specific, the natural compounds from the Capparaceae family which has been proved to have antioxidant, anti-inflammatory, antimicrobial and anti-carcinogenic activities, by several studies. Cleome arabica L. (CA) specie is the most used medicinal plants in Tunisia and elsewhere in North African countries for treatment of various diseases including diabetes, rheumatism, inflammation, cancer, and digestive disorders. The current work was undertaken to estimate the total phenolic, flavonoid and condensed tannin contents, to identify and quantify the polyphenolic compounds, and to evaluate the antioxidant and the anti-inflammatory proprieties of CA fruits extract against formalin induced chronic inflammation in Female Wistar rats. In fact, the antioxidant activity was tested by Diphenyl-1-Picrylhydrazyl free radical scavenging (DPPH), Ferric reducing antioxidant power (FRAP) and Nitric Oxide radical (NO·). Anti-inflammatory effect of fruits extract was examined using formalin (2%) induced paw edema in rats. Molecular docking tools were used to investigate the interaction of some compounds from CA fruits extract with the cyclooxygenase-2 (COX-2) target protein. Our results showed that, the total phenolic, flavonoid and tannins contents, which were assessed by the Folin-Ciocalteu, Quercetin, and Catechin methods, respectively, were 230.22 mg gallic acid equivalent/g dry weight (mg GAE/g DW), 55.08 mg quercetin equivalent/g dry weight (QE/g DW) and 15.17 mg catechin equivalents/g dry weight (CatE/g DW), respectively. HPLC analysis revealed the presence of five polyphenolic compounds whose catechin was found to be the most abundant compounds. The antioxidant activity of extract was quantified by DPPH, FRAP and NO· tests and IC50 reached the values of 3.346 mg/mL, 2.306 and 0.023 mg/mL, respectively. Cleome fruits ameliorated the histological integrity of the skin and alleviated the disruptions in hematological parameters (WBC, LYM, RBC, and HGB), inflammatory cytokines (IL-1β, IL-6, TNF-α), C-reactive protein, and some oxidative stress markers (TBARS (−49%) and AOPP (−42%) levels, SOD (+33%) and GPx (+75%) activities, and GSH (+49%) content) induced by formalin injection. Moreover, the in-silico investigation had shown that CA fruits extract compounds have a stronger interaction with COX-2 active site, more than the reference drug “indomethacin” (two H-bonds). Our research gives pharmacological backing to the healthcare utilization of Cleome plant in the treatment of inflammatory diseases and oxidative harm.

1. Introduction

Chronic inflammatory illnesses are one of the very common lowering factors of life and are among the most common death causes [1]. The inflammatory response is initiated by mast cell activation associated with the release of several vasoactive components such as bradykinin, histamine, prostaglandins and serotonin [2]. The complex inflammatory process was orchestrated by various pro-inflammatory mediators such as interleukin-1 beta (IL-1β), Interleukin-6 (IL-6), and Tumor necrotic factor-alpha (TNF-α) [3]. The persistence of inflammation increased the risk of several diseases such as cancer, rheumatoid arthritis and skin inflammation [4,5].
Several nonsteroidal anti-inflammatory drugs (NSAIDs) exert their effect by inhibiting cyclooxygenases (COXs) which catalyzes the of arachidonic acid (AA) metabolism in prostaglandins (PGs) and thromboxanes (TXs) [6,7]. COX was shown to exhibit three isoforms, those being COX-1, COX-2 and COX-3 [8]. The constitutive enzyme COX-1 is involved in the production of physiological PGs and TXs which control, respectively, the protection of the gastric mucosa, kidney function and platelet aggregation, acting as a “housekeeper” enzyme [7,9,10]. Further, at an infectious or inflammatory site, COX-2 is induced as a response to the release of pro-inflammatory mediators and therefore catalyzes the release of pathological PGs involved in the inflammatory process [11,12]. Despite their efficacy in treating pain and inflammation [13,14], NSAIDs have serious side effects such as gastrointestinal and cardiovascular complications [15].
In recent years, research on medicinal plants has increased worldwide due to their broad pharmaceutical and/or veterinary phytopharmacology applications [16,17]. In fact, Medicinal plants contain many bioactive molecules which are not only used in traditional medicine and as food’s spices but also in pharmaceutical industry [18,19,20]. Among these molecules the phenolic acids, tannins and flavonoids possess important biological properties such as antimicrobial, anti-inflammatory, anticarcinogenic and antioxidant activities [21,22]. Among these plants, Cleome arabica L. (CA) has attracted a great deal of interest in the search for antioxidant and anti-inflammatory molecules. This plant belongs to the Capparaceae family, which includes several species (over 200 species), and it is widely cultivated in the tropics and subtropics of the world, especially in North Africa [23].
CA is a spontaneous Saharan plant, known as “Mnitna” due to its foul smell, which is widely scattered in the sandy zones of Tunisia. This genus is a very significant source of bioactive compounds and has numerous healing and conventional applications [24]. Previous studies have proved CA’s phytotherapeutic benefits of, in alleviating several diseases such as rheumatic pain and cancer [25,26]. Recently, the aqueous extracts are extensively studied as a possible anti-inflammatory treatment [27,28].
Therefore, the purpose of our study was undertaken with the aim of identifying and quantifying the phenolic compounds of Cleome Arabica L. fruits extract and evaluating their antioxidant activities. Additionally, we investigated the potential anti-inflammatory effects of fruits extract against formalin induced chronic inflammation in Female Wistar rat using biochemical, and histological assays. Furthermore, Molecular docking was used to characterize the structures of ligand protein complexes and to estimate the free binding energies of docked ligands. This phytochemical characterization of CA fruits extract and their antioxidant and anti-inflammatory effects were carried out in order to revalorize this wild plant as a natural source of bioactive molecules, which are effective in the treatment of pain and inflammation instead of synthetic drugs.

2. Results and Discussion

2.1. Total Phenolic, Flavonoid and Tannins Contents

Aqueous extract of CA fruits was evaluated for their total phenolic, flavonoid and tannins amounts (Table 1). The total phenolic content in the aqueous extract of CA was 230.22 ± 7.08 mg GAE/g DW. The found amount of flavonoids was around 55.08 ± 1.28 mg QE/g DW. In addition, our results proved that Cleome fruits aqueous extract is rich in tannins (15.17 ± 0.47 CatE/g DW). The phytochemical investigation of the aqueous extract of CA revealed important levels of polyphenols, flavonoids and tannins compared with previous reports [29]. Several studies have indicated that these polyphenols are mainly accountable for the antioxidant potential and anti-inflammatory properties of multiple medicinal plants [30,31]. In addition to phenolic and flavonoid, tannins are widespread and important bioactive molecules in plant. Tannins have a potent antioxidant and antibacterial activities [32,33].

2.2. HPLC Analysis of Phenolic Compounds

The HPLC analysis was used to determine the composition of the polyphenolic compounds in CA fruits extract. Peak identification was based on their retention times, their UV–Vis and mass spectra together with data from the literature. Five phenolic compounds (Quercetin, Catechin, Kaempferol, Rosmarinic acid and Naringenin) were identified (Table 2). The major content was picked for catechin 5.45 mg/g followed by quercetin 3.45 mg, kaempferol 3.23 mg/g and naringenin 2.84 mg/g. Our results showed that rosomarinic acid was the minor compound (0.12 mg/g) amid the phenolic compounds mentioned. The HPLC analysis has provided more precise information on the chemical nature of the bioactive compounds abundant in the CA fruits. These data were correlated to an earlier study in which Cleome arabica L. was rich in phenolic compounds such as kaempferol and quercetin [23,34,35]. Moreover, several studies have indicated that these polyphenols are mainly accountable for the antioxidant potential and anti-inflammatory properties of multiple medicinal plants [30,31].

2.3. Antioxidant Activity

The antioxidant capacity of the CA fruits extract was studied with three assays such as free radical scavenging (DPPH), reducing power (FRAP) and nitric oxide radical (NO·). The results are summarized in Table 3. The aqueous extract exhibited an IC50 of DPPH (IC50 = 3.346 ± 0.12 mg/mL), FRAP (IC50 = 2.306 ± 0.05 mg/mL) and NO· (0.023 ± 0.001 mg/mL) than is higher the IC50 of vitamin C which is used as a positive control. In this study, CA can be introduced as an important natural antioxidant to scavenge DPPH, NO· and FRAP radicals. The reducing power of CA fruits extract is important to reduce the Fe3+/ferricyanide complex to the ferrous form. Therefore, aqueous extract can scavenge free radicals at low concentrations. Our research’s findings of are coherent with the observation by Chen et al. (2013), who mentioned that the highest antioxidant capacity of phenolic compounds is related to the lower bond dissociation energies of OH groups [36]. In addition, Erdogan Orhan et al. (2019) found that catechin exhibited a strong ability to scavenge DPPH radicals [37].

2.4. Anti-Inflammatory Effects of Cleome on Edema Size

As indicated in Figure 1, subcutaneous injection of formalin for 7 days significantly increased the size of edema in FOR group compared to control group, which exhibited normal paw size. The treatment with CA fruits extract (FOR+CA) or INDO (FOR+INDO) mainly reduced the size of edema after the 4th day. As represented in Table 4, Cleome fruits extract inhibited the development of inflammation (55%) more effectively than INDO (45%) (p < 0.05). The anti-inflammatory effect of CA was significantly greater than that of INDO from the 5th day (p < 0.05).The formalin-induced paw edema was extensively used as a model to evaluate the anti-inflammatory effect of plants in chronic inflammation as it closely resembles human arthritis [38]. The reduction in inflammation by the CA fruits extract decreased the edema size more than positive INDO treatment which was used as a drug reference to compare with, in this work [28]. The CA fruits extract inhibition of inflammation was found to be greater than that induced by INDO as a reference drug (55% vs. 45%). Therefore, this could be partly, caused by the decrease of the release of inflammatory mediators by phytochemicals compounds in CA fruits extract. Although, numerous in vivo studies have shown that different Cleome species have inhibited inflammation in carrageenan-induced paw edema [39]. However, the mechanism pathway remains unclear and/or incomplete.

2.5. Hematological Findings

The injection of formalin induces a disruption in hematologic parameters (Figure 2). Lymphocytes proportion and WBC in FOR group was significantly (p < 0.01) increased once compared to control group. RBC and HGB were significantly reduced in FOR rats in comparison with healthy rats. Disruptions in hemogram parameters were restored by following treatments of rats with CA or INDO. The inflammatory response consists in the increase of blood vessels permeability leading to the migration and activation of PMNs [40]. In this study, disruptions in hematological parameters (WBC and lymphocytes) were highly significant increase in FOR group. WBC is the key element of the immune system which is related to the initiation of inflammation. They were the predominant cells in chronic inflammation [41]. However, RBC and hemoglobin (Hb) hematological markers were decreased. Reduced levels of Hb emphasized the degradation of premature RBCs and decreased erythropoietin. As a result, an anemic condition developed due to erythrocyte deformation [42,43]. Similar to the previous study, these changes in hematological parameters could be explained by the reduced activity of the immune system [44]. The administration of CA resulted in the restoration of hematological parameters to reach normal levels. Thus, this study is in line with the previous one which showed that the administration of CA alleviated anemia in chronic inflammation [45].

2.6. C-Reactive Protein (CRP) and Pro-Inflammatory Cytokines Profiling

As demonstrated in Figure 3, formalin injection increased dramatically CRP levels in FOR group when compared to control. However, a statistically significant decrease of this parameter was observed in rats pre-treated with CA (p < 0.05) or INDO (p < 0.001) in comparison with FOR group. No significant difference was noted between FOR+CA and FOR+INDO groups. Figure 3 showed the serum levels of pro-inflammatory cytokines in experimental rats. Formalin administration resulted in a rise in IL-1β, IL-6 and TNF-α quantities once compared with the control group. The pre-treatment with Cleome fruits extract decreased these cytokines levels as well, and its effect was superior to that of INDO. Chronic inflammation is characterized by the release of cytokines mediators such as IL-1β, IL-6 and TNF-α. Based on our findings, formalin injection resulted in a rise in CRP, IL-1, IL-6 and TNF-α level in FOR group when compared with control rats. TNF-α, as an important inflammatory cytokine, could stimulate neutrophils to liberate proteases and oxygen-free radicals [46]. During the inflammatory process, IL-6 induces the activation of lymphocytes, promotes endothelial cells to produce chemokines and facilitates inflammatory cells infiltration into the injured site [47]. In general, the anti-inflammatory process is associated with a decrease in nuclear factor-κB (NF-κB) and interleukin levels [48]. CRP is considered a very expedient indicator of inflammation in the tissue. The injection of formalin induced a highly significant rise in CRP marker in FOR group. This confirms the cumulative effect of formalin on chronic inflammation. The acute phase of protein synthesis, as CRP is triggered during inflammatory reactions [49]. This protein was produced by local inflammatory cells in damaged tissues, but it is principally produced in the liver [50]. However, CA fruits extract had importantly lowered the levels of CRP, IL-1, IL-6 and TNF-α in rats, suggesting that the Cleome fruits extract plant has a potential anti-inflammatory effect.

2.7. Effect of Cleome Fruits Extract on Oxidative Stress Status

Subcutaneous formalin injection not only led to the production of pro-inflammatory cytokines but also to the release of reactive spices of oxygen (ROS). This chronic inflammation was associated with increased lipid peroxidation and protein oxidation in FOR group. As illustrated in Table 5, MDA and AOPP levels showed an increase in this group when compared to control group. After formalin injection, a significant decrease in SOD and GPx activities was noted as well as a reduction in GSH levels in FOR group. Oxidative stress markers, notably MDA and AOPP, were found to be reduced following treatment with Cleome fruits extract (CA) or INDO as compared to FOR group. Pre-treatment with CA fruits extract or INDO reinstated antioxidant activities and levels to near normal levels. Mainly, the alleviation of the oxidative stress with CA fruits extract was clearly more evident than the reference drug. Oxidative stress is defined as overexpression of reactive oxygen species (ROS) which altered the function of various biological systems. This extra physiological situation is considered as an important pathological disorder associated with formalin chronic inflammation phenomena [51]. Indeed, lipid peroxidation is mostly used as an indicator of oxidative tissue injury leading to inflammation and cell necrosis [52,53]. Therefore, the enzymatic antioxidants such as SOD and GPx and the non-enzymatic antioxidant (GSH) declines are usually considered excellent biomarkers which leads to the weakening of the whole antioxidant system [54]. Oxidative stress is strongly linked to acute and chronic inflammation in the animal model [28,55]. However, this situation was reversed through the administration of CA fruits extract to rats. The administration of Cleome fruits extract to rats had decreased oxidative stress products and increased the antioxidant defense system. The reduction in lipid peroxidation and protein oxidation (AOPP) in rats treated with CA fruits extract could be explained by the enzymatic action and/or free radical scavenging activity of its compounds. Additionally, phenolic compounds such as quercetin and catechin found in many foods and vegetables have potent antioxidant effects. Indeed, oxidants caused by endothelial apoptosis are improved by quercetin, so it is more effective than other antioxidant nutrients (beta-carotene, glutathione and vitamins C and E) [56,57]. This property could be the result of two antioxidant pharmacophores inside the quercetin molecule, which is optimally configured for the sweeping of free radicals [58]. Moreover, its ability to chelate iron and other transition metal ions enabling it also to prevent the iron-catalyzed Fenton reaction [59].

2.8. Effect of Cleome Fruits Extract on Formalin-Induced Histological Alterations

In order to assess the anti-inflammatory effect of CA fruits extract against chronic inflammation, we carried out a histopathological analysis of paw tissue from all groups was carried out (Figure 4). FOR group showed acute edema associated with mononuclear inflammatory cell infiltration compared to the Control group with no histological injuries. Examined paw sections of rats receiving CA fruits extract revealed a weak inflammatory reaction. Similarly, the reference drug (INDO) reduced the histological damage induced by formalin. Histological examination of rat paw revealed that formalin injection induced an increase in skin thickness owing to edema development. Edema resulted from the increased vasculature permeability with greater vasodilatation [60]. Skin sections indicated dilatation of the blood vessels as a result of inflammatory cell infiltration. Eltom et al. (2021) [61] detected inflammatory cells infiltration, mainly in the dermal layer and the basal part of the epidermis. These histopathological assessments proved the presence of chronic inflammation. Similarly, Kim et al. (2010) showed the presence of necrotic debris, lymphocyte infiltration and hypertrophy in the subcutaneous regions [62]. The effect of formalin injection in skin tissue has been previously studied [63]. The administration of Cleome fruits extracts protected skin tissue against inflammatory signs.

2.9. Molecular Docking Studies

The preventive effect of CA fruits extract may be due to the presence of many phenolic compounds such as quercetin, catechin, kaempferol and flavonoid contents (results approved in our previous research). Therefore, the anti-inflammatory proprieties of plants rich in flavonoids could be induced by the inhibition of some key enzymes involved in the inflammation process, such as COX receptors [64]. In this context, COX-2 enzyme is a target for a wide range of many anti-inflammatory drugs as it is responsible for production of PGs inducing inflammation. The current work investigated by molecular docking the interaction of some compounds from CA fruits extract with the binding site of COX-2. The interaction of formalin and the reference drug with COX-2 active site were analyzed to predict their binding mode and to explain their anti-inflammatory activity using AutoDock vina software. The five identified compounds of the extract (catechin, quercetin, kaempferol, rosmarinic acid, and naringenin) subjected to molecular docking fitted well to COX-2 active site inside the pocket and showed good binding energy scores ranged from −6.5 to −9.8 Kcal/Mol compared to the reference drug INDO (−5.4 Kcal/Mol). Table 6 recapitulated the docking results: binding affinities, number of conventional H-bonds and interacting amino acid residues. The best binding energy was found with catechin (−9.8 Kcal/mol) which displayed six H-bonds in addition to some hydrophobic interactions (Figure 5). Catechin was bonded to His75, Ser339, Leu338, Val335, Gln178 and Ser516 via hydrogen bonds. Kaempferol, the 2nd compound displaying an energy of −9.4 Kcal/mol, had established only two H-bonds. Rosmarinic acid despite having a higher energy value than kaempferol, it showed five H-bonds. INDO was bound to the active site via two H-bonds, Arg106 and Tyr341 (Figure 6). Regarding these obtained data, it may be concluded that in term of conventional H-bonds and binding affinity, the interactions of all CA compounds were much more effective than the reference drug. Therefore, docking study demonstrated that catechin which exhibits the optimal binding energy score and the highest number of H-bond could be a potential therapeutic candidate against COX-2.
These findings confirmed previously reported data on the effects of certain phytochemicals compounds belonging to Cleome through in silico and molecular docking [65,66,67]. Indomethacin created two hydrogen bonds only together with lower interaction scores (−5.4). Hence, indomethacin seemed unassociated with rosmarinic acid (−8.0), and quercetin (−6.5). These compounds were further detailed and compared to indomethacin interactions (Table 6). Moreover, Val 335 and Leu 338 were the most involved COX-2 residues. This may justify their important role in the COX-2 binding and inhibition during the inflammatory process [68]. The 3D illustration and the 2D diagram of interactions exhibit that the selected compounds are bound to COX-2 through a network of electrostatic, hydrophobic and hydrogen bonds [69]. In addition, all the compounds evaluated showed negative binding energy, which may explain the Cleome anti-inflammatory effect as described by the biochemical and histological tests.

3. Materials and Methods

3.1. Plant Material

The aerial part of CA was collected at the fructification phenological stage between March–April 2019 from Sbeitla-Kasserine (35°14′ N, 9°08′ E, Tunisia). Dr Zouhaier Noumi (Faculty of Science of Sfax, Tunisia) performed the plants identification according to the flora of Tunisia (Pottier-Alapatite, 1979). The reference specimen was deposited in the Herbarium of the Laboratory of Animal Physiology, Faculty of Sciences of Sfax. P.O. Box 95, Sfax 3052, Tunisia. The fresh fruits were separated, washed with distilled water, dried at room temperature for 15 days and crushed to obtain a fine powder.

3.2. Characterization of the Plant Extract

3.2.1. Preparation of the Plant Extract

The dried samples (1 g) were macerated in 8 ml of distilled water. The aqueous extract prepared and filtered using Whatman filter paper. Final extracts were kept in vials at 4 °C until their corresponding analyses.

3.2.2. Total Phenolic Content (TPC)

A colorimetric method of Folin-Ciocalteu was used to determine the total phenolic content [70]. The reaction mixture contained 100 μL of samples and 500 μL of Folin-Ciocalteu reagent (10%). The mixture reacted for 3 min before 400 μL Na2CO3 (2%) was added. The absorbance was measured at 750 nm after 30 min of incubation of the mixture in the dark. The amount of TPC is expressed in mg of gallic acid equivalent per g of dry weight (mg GAE/g DW). Analyses were carried out in triplicate.

3.2.3. Total Flavonoid Content

The total flavonoid content was measured spectrophotometrically in the extract [71]. This procedure consists of the formation of the aluminum-flavonoid complex. A total of 125 μL of the sample was mixed with 37.5 μL NaNO2 (5%) and incubated for 5 min. Next, 37.5 μL AlCl3 (10%) was added to the mixture. After 6 min of incubation, 250 μL NaOH (1M) and 300 μL H2O were added to the mixture. The maximum absorbance was measured at 510 nm. The results were expressed as mg of quercetin equivalent per g of dry weight (mg QE/g DW). All measurements were performed in triplicate.

3.2.4. Determination of Condensed Tannins Content

The tannin assay was performed as follows: 50 μL of the extract, 3 mL of vanillin (4% in methanol), and 1.5 mL of H2SO4 (9 N in methanol) were mixed. After 15 min, the absorbance was measured at λ = 500 nm [72]. Tannin content was calculated from the catechin regression equation. The tannins concentration was expressed as mg catechin equivalent/g dry weight (mg CatE/g of dry weight).

3.2.5. HPLC Analysis

Phenolic compounds in the Cleome fruits extract were identified using HPLC analysis according to Zheng and Wang, 2001 [73]. The method consisting of a vacuum degasser, autosampler, binary pump with a maximum pressure of 400 bar and an Agilent 1260, Agilent Technologies, Germany, equipped with a reversed-phase C18 analytical column of 4.6 × 100 mm and 3.5 μm particle size (Zorbax Eclipse XDB C18). The DAD detector was set to a scanning range of 200–400 nm. The column temperature was maintained at 25°C. The injected sample volume was 2 μL and the flow rate of the mobile phase was 0.4 mL/min. Mobile phase B was Milli-Q water consisting of 0.1% formic acid and mobile phase A was Methanol. The optimized gradient elution was illustrated as follows: 0–5 min, 10–20% A; 5–10 min, 20–30% A; 10–15 min, 30–50% A; 15–20 min, 50–70% A; 20–25 min, 70–90% A; 25–30 min, 90–50% A; 30–35 min, return to initial conditions. Identification analysis was carried outby comparison of their retention time with those obtained from the extract. For the quantitative analysis, a calibration curve was obtained by plotting the peak area against different concentrations for each identified compound at 280 nm. Phenolic compounds contents were expressed in mg of compounds per gram of dry weight (mg/g DW).

3.2.6. DPPH• Free Radical Scavenging Activity

The antioxidant activity of the extract is based on its ability to scavenge 2,2-diphenyl-1-picrylhydrazyl (DPPH•) radical [74]. A dilution series was prepared for the plant extract. The reaction mixture contains 0.5 mL of the extract and 1 mL of DPPH solution (0.4 mM) in methanol. The mixture was incubated in a dark room for 30 min at room temperature. Ascorbic acid was used as a standard. The reduction in the DPPH- free radical was measured using a spectrophotometer at 517 nm. The percentage inhibition (PI) of the radicals was estimated using the following formula:
%I = ((A0 − AS)/A0) ×100
A0: The absorbance of the control
As: The absorbance of the samples
The results were expressed as the inhibitory concentration of the extract needed to decrease DPPH• absorbance by 50% (IC50). Concentrations are expressed as mg/mL.

3.2.7. Ferric Reducing Antioxidant Power (FRAP)

The reducing efficacy determines the antioxidant ability of CA fruits extract to reduce the ferric iron in the ferricyanide complex Fe3+ to ferrous iron Fe2+. This reduction results in a green color whose intensity is proportional to the reducing power [75]. A total of 2.5 mL phosphate buffer (0.2 M, pH 6.6) and 2.5 mL K3[Fe(CN)6] (1%) were added to different concentrations of sample (0–1 mg/mL). The mixture was incubated for 20 min at 50 °C. Next, 2.5 mL TCA (10%) was added to their action and centrifuged for 10 min at 3000 rpm. Finally, 2.5 mL distilled water and 0.5 mL of FeCl3 were added to the 2.5 mL aliquots. The absorbance was read at 700 nm. The tested compound concentration, which provides 50% inhibition (IC50, expressed in mg/mL), was calculated from the graph plotting the inhibition percentage against the extract concentration and confirmed by IBM SPSS software.

3.2.8. Nitric Oxide Radical (NO·) Inhibition

The nitric oxide radical scavenging activity of CA fruits extract was determined using the method described by Green et al. (1982) [76]. The concentration of the test extract, which provided 50% inhibition (IC50, expressed as mg/mL), was calculated from the graph representing the percentage inhibition as a function of extract concentration. Ascorbic acid was used as a positive control.

3.3. In Vivo Study

3.3.1. Animals and Experiment Design

Female Wistar rats weighting 200–220 g were used in the current study. They were housed in the stainless-steel cages under laboratory conditions of 12 h light/ dark cycle and at temperature and humidity-controlled room. Animals were divided into four groups of six rats each. In this study, the chronic inflammation was induced by subcutaneous plantar injection of formalin (2%) for seven days as previously described [77].
-
Control group: rats injected with physiological serum 0.1 mL/kg of body weight and served as a control group.
-
FOR group: rats injected by 0.1 mL of 2% formalin for 7 days.
-
FOR+CA group: rats received Cleome fruits extract (50 mg/kg of body weight), by gavage, 30 min before formalin injection.
-
FOR+INDO group: rats received indomethacin (10 mg/kg of body weight), by gavage, 30 min before formalin injection.
Cleome fruits extract (CA) and indomethacin (INDO) were administered to rats one week prior to formalin injection (2%). In the infected model, the increase in paw edema was measured by vernier caliper method [78].

3.3.2. Sample Collection

Blood samples were collected by decapitation and putting the rat’s neck into EDTA tubes for the determination of hematological parameters. Other blood samples were putted in heparin tubes, and they used for serum separation by centrifugation. The obtained serum was stored at −80 °C until analyzed.
To obtain homogenate from the inflamed skin, tissues (edema) were dissected out and diluted with phosphate buffer saline (pH = 7.4) and centrifuged for 20 min at 9000 rpm. The obtained supernatant was collected and used for oxidative stress testing.

3.3.3. Hematological Parameters Determination

Red Blood Cells count (RBC, 106/μL), White Blood Cells count (WBC, 103/μL), Lymphocytes proportion (Lym, %) and Hemoglobin (HGB, g/dL) were quantified using an automatic SYSMEX SERIE KX-21N hematology analyzer, CHU Habib Bourguiba, Sfax, Tunisia.

3.3.4. Determination of Inflammatory Mediators

C-reactive protein (CRP) is a specific producer of inflammatory process. It increases in proportion to its intensity [79]. The reactive protein was measured by the turbidimetric method using an automatic analyzer COBAS INTEGRA 400″ C-Reactive. The CRP is expressed in mg/L.
IL-1β, IL-6, and TNF-α levels were measured in the plasma samples by enzyme-linked immunosorbent assay using commercially ELISA kits (R&D System, Minneapolis, MN, USA), according to the manufacturer’s instructions. The results were expressed as µg/mL.

3.3.5. Assessment of Oxidative Stress Parameters in Paw Tissue

The initial step was to determine protein quantity in skin tissue according to the method of Oh (1951) [80]. The lipid peroxidation was assessed by analyzing the level of malondialdehyde (MDA) following the method designed by Fraga et al. (1988) [81]. The amount of MDA was measured at 532 nm and expressed as nmoL/mg of protein.
Advanced oxidation of protein products (AOPP) was measured spectrophotometrically at 340 nm as previously described by Witko et al. (1996) [82]. The concentration of AOPP was calculated using the extinction coefficient of 261 cm/mM. The results were expressed as µmoL/mg of protein.
The method developed by Beauchamp and Fridovich [83] was used to evaluate superoxide dismutase (SOD) activity. SOD activity was measured at 580 nm and given as U/mg of protein. Glutathione peroxidase (GPx) activity was determined by the procedure of Flohe and Gunzler [84]. Data are expressed as µmoL of GSH/mg of protein. Glutathione reductase (GSH) level was assessed using the method of Jollow et al. (1974) [85]. The obtained results were expressed as µmoL/mg of proteins.

3.3.6. Histopathological Examination

Paraffin portions of dermal tissues were cut into small sections of 7 μm, then stained with hematoxylin-eosin solution (H&E) and examined under light microscopy at 40× magnifications.

3.4. Molecular Docking Procedure

Molecular docking simulation was performed by Auto Dock 4.2 program package [86]. The X-ray crystallographic structure of cyclooxygenase-2 (PDB: 3LN1) with selective inhibitor celecoxib was downloaded from the RSCB protein databank [87]. COX-2 enzyme/protein (3LN1) contains the four symmetrical chains A, B, C and D with different native ligands named BOG (β-Octylglucoside), CEL (celecoxib), HEM (Protoporphyrin IX contains Fe) and last NAG (N-acetyl-D-glucosamine). The chain A was selected for the docking studies. The receptor grid was generated (with all default parameters) around the native ligand CEL (celecoxib) by picking it. The optimization of all the geometries of compounds was carried out using ACD (3D viewer) software (http://www.filefacts.com/acd3d-viewer-freeware-info (accessed on 30 January 2010)). The visualization and analysis of interactions were performed using Discovery Studio 2017R2 (https://www.3dsbiovia.com/products/collaborative-science/biovia-discovery-studio/ (accessed on 30 January 2010)).

3.5. Statistical Analysis

The data are expressed as mean ± standard error of the mean (SEM). The obtained results were analyzed statistically by ANOVA followed by the Tukey method for post-hoc analysis, using the GraphPad Prism software. P value of less than 0.05 was regarded as statistically significant.

4. Conclusions

In this research, Cleome fruits extract has been proven to be an effective potential source of polyphenols and a useful alternative that replaces or even decreases the use of synthetic antioxidants in foods, cosmetics and pharmaceutical products. The efficient correlation between the polyphenolic content and the antioxidant capacity proved that the polyphenolic constituents are responsible for the antioxidant activity of Cleome. Based on our study’s results, it was concluded that formalin sub-chronic administration induces increases in inflammatory cytokines (IL-1β, IL-6, TNF-α), C-reactive protein, and oxidative stress (TBARS, AOPP, SOD, GPx, GSH), which is caused by formalin injection in rats. Moreover, the in vivo and in silico studies showed that the aqueous extract of CA possesses a greater anti-inflammatory effect than the reference drug (INDO.). This potential could be associated to the existence of phytochemicals natural compounds such as flavonoids (quercetin and kaempferol). Therefore, these results could be exploited in the development of new natural pharmaceutical drugs that have anti-edematous, anti-inflammatory and antioxidant activities with fewer side effects.

Author Contributions

I.A., M.J. and M.S.A. conceptualized and designed the study. I.A. collected the medicinal plant material. I.A., M.H., N.Z., A.E. and C.K. carried out the experimental work. I.A., M.H., K.H., H.B.J. and M.S.A. performed the data analysis. I.A. and K.H. wrote the first draft of the manuscript. I.A., N.Z., K.H., A.H.H. and M.S.A. critically revised the manuscript. L.M., S.A. and A.H.H. reviewing, visualization and finding acquisition. The manuscript has been read and approved by all the authors and each author believes that the manuscript represents honest work. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

The data presented in this study are available on request from the corresponding author.

Acknowledgments

The authors thank the “Ministry of Higher Education, Scientific Research and Technology, Tunisia”, for the support of this study. They also extend their appreciation to Researchers Supporting Project number RSP202317, King Saud University, Riyadh, Saudi Arabia.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Jantan, I.; Haque, M.d.A.; Arshad, L.; Harikrishnan, H.; Septama, A.W.; Mohamed-Hussein, Z.A. Dietary polyphenols suppress chronic inflammation by modulation of multiple inflammation-associated cell signaling pathways. J. Nutr. Biochem. 2021, 93, 108634. [Google Scholar] [CrossRef] [PubMed]
  2. Dhanisha, S.S.; Drishya, S.; Guruvayoorappan, C. Fruit Extract of Pithecellobium dulce (FPD) ameliorates carrageenan-induced acute inflammatory responses via regulating pro-inflammatory mediators. J. Food Biochem. 2020, 44, e13329. [Google Scholar] [CrossRef] [PubMed]
  3. An, J.; Chen, B.; Kang, X.; Zhang, R.; Guo, Y.; Zhao, J.; Yang, H. Neuroprotective effects of natural compounds on LPS-induced inflammatory responses in microglia. Am. J. Transl. Res. 2020, 12, 2353–2378. [Google Scholar] [PubMed]
  4. Greten, F.R.; Grivennikov, S.I. Inflammation and Cancer: Triggers, Mechanisms, and Consequences. Immunity 2019, 51, 27–41. [Google Scholar] [CrossRef] [PubMed]
  5. Mzid, M.; Ben Khedir, S.; Bardaa, S.; Sahnoun, Z.; Rebai, T. Chemical composition, phytochemical constituents, antioxidant and anti-inflammatory activities of Urtica urens L. leaves. Arch. Physiol. Biochem. 2017, 123, 93–104. [Google Scholar] [CrossRef] [PubMed]
  6. Faria, J.V.; Vegi, P.F.; Miguita, A.G.C.; dos Santos, M.S.; Boechat, N.; Bernardino, A.M.R. Recently reported biological activities of pyrazole compounds. Bioorg. Med. Chem. 2017, 25, 5891–5903. [Google Scholar] [CrossRef]
  7. Pavase, L.S.; Mane, D.V.; Baheti, K.G. Anti-inflammatory Exploration of Sulfonamide Containing Diaryl Pyrazoles with Promising COX-2 Selectivity and Enhanced Gastric Safety Profile. J. Heterocycl. Chem. 2018, 55, 913–922. [Google Scholar] [CrossRef]
  8. Vahedpour, T.; Kaur, J.; Hemmati, S.; Hamzeh-Mivehroud, M.; Alizadeh, A.A.; Wuest, F.; Dastmalchi, S. Synthesis and Biological Evaluation of 1,3,5-Trisubstituted 2-Pyrazolines as Novel Cyclooxygenase-2 Inhibitors with Antiproliferative Activity. Chem. Biodivers. 2021, 18, e2000832. [Google Scholar] [CrossRef]
  9. Abdelgawad, M.A.; Labib, M.B.; Ali, W.A.M.; Kamel, G.; Azouz, A.A.; EL-Nahass, E.S. Design, synthesis, analgesic, anti-inflammatory activity of novel pyrazolones possessing aminosulfonyl pharmacophore as inhibitors of COX-2/5-LOX enzymes: Histopathological and docking studies. Bioorg. Chem. 2018, 78, 103–114. [Google Scholar] [CrossRef]
  10. Abdellatif, K.R.A.; Fadaly, W.A.A. New 1,2-diaryl-4-substituted-benzylidene-5-4H-imidazolone derivatives: Design, synthesis and biological evaluation as potential anti-inflammatory and analgesic agents. Bioorg. Chem. 2017, 72, 123–129. [Google Scholar] [CrossRef]
  11. Hu, X.; Zhang, Y.A.; Chen, B.; Jin, Z.; Lin, M.L.; Li, M.; Mei, H.X.; Lu, J.C.; Gong, Y.Q.; Jin, S.W.; et al. Protectin DX promotes the inflammatory resolution via activating COX-2/L-PGDS-PGD2 and DP1 receptor in acute respiratory distress syndrome. Int. Immunopharmacol. 2022, 102, 108348. [Google Scholar] [CrossRef]
  12. Nkadimeng, S.M.; Steinmann, C.M.L.; Eloff, J.N. Anti-Inflammatory Effects of Four Psilocybin-Containing Magic Mushroom Water Extracts in vitro on 15-Lipoxygenase Activity and on Lipopolysaccharide-Induced Cyclooxygenase-2 and Inflammatory Cytokines in Human U937 Macrophage Cells. J. Inflamm. Res. 2021, 14, 3729–3738. [Google Scholar] [CrossRef]
  13. Machado, G.C.; Abdel-Shaheed, C.; Underwood, M.; Day, R.O. Non-steroidal anti-inflammatory drugs (NSAIDs) for musculoskeletal pain. BMJ 2021, 104, 372. [Google Scholar] [CrossRef] [PubMed]
  14. McMahon, S.B.; Dargan, P.; Lanas, A.; Wiffen, P. The burden of musculoskeletal pain and the role of topical non-steroidal anti-inflammatory drugs (NSAIDs) in its treatment. Ten underpinning statements from a global pain faculty. Curr. Med. Res. Opin. 2021, 37, 287–292. [Google Scholar] [CrossRef]
  15. Harirforoosh, S.; Asghar, W.; Jamali, F. Adverse Effects of Nonsteroidal Antiinflammatory Drugs: An Update of Gastrointestinal, Cardiovascular and Renal Complications. J. Pharm. Pharm. Sci. 2013, 16, 821–847. [Google Scholar] [CrossRef] [Green Version]
  16. Selvi, S.; Polat, R.; Çakılcıoğlu, U.; Celep, F.; Dirmenci, T.; Ertuğ, Z. An ethnobotanical review on medicinal plants of the Lamiaceae family in Turkey. Turk. J. Bot. 2022, 46, 283–332. [Google Scholar] [CrossRef]
  17. Güler, O.; Polat, R.; Karakose, M.; Cakılcıoğlu, U.; Akbulut, S. An ethnoveterinary study on plants used for the treatment of livestock diseases in the province of Giresun (Turkey). S. Afr. J. Bot. 2021, 142, 53–62. [Google Scholar] [CrossRef]
  18. Kalyniukova, A.; Holuša, J.; Musiolek, D.; Sedlakova-Kadukova, J.; Płotka-Wasylka, J.; Andruch, V. Application of deep eutectic solvents for separation and determination of bioactive compounds in medicinal plants. Ind. Crops Prod. 2021, 172, 114047. [Google Scholar] [CrossRef]
  19. Süntar, I. Importance of ethnopharmacological studies in drug discovery: Role of medicinal plants. Phytochem. Rev. 2020, 19, 1199–1209. [Google Scholar] [CrossRef]
  20. Çakılcıoğlu, U. An ethnobotanical field study; Traditional foods production and medicinal utilization of Gundelia L. species in Tunceli (Turkey). Indian J. Tradit. Knowl. 2020, 19, 714–718. [Google Scholar]
  21. Chand, J.; Panda, S.R.; Jain, S.; Murty, U.; Das, A.M.; Kumar, G.J.; Naidu, V. Phytochemistry and polypharmacology of cleome species: A comprehensive Ethnopharmacological review of the medicinal plants. J. Ethnopharmacol. 2022, 282, 114600. [Google Scholar] [CrossRef] [PubMed]
  22. Khuntia, A.; Martorell, M.; Ilango, K.; Bungau, S.G.; Radu, A.-F.; Behl, T.; Sharifi-Rad, J. Theoretical evaluation of Cleome species’ bioactive compounds and therapeutic potential: A literature review. Biomed. Pharmacother. 2022, 151, 113161. [Google Scholar] [CrossRef] [PubMed]
  23. Ladhari, A.; Omezzine, F.; DellaGreca, M.; Zarrelli, A.; Zuppolini, S.; Haouala, R. Phytotoxic activity of Cleome arabica L. and its principal discovered active compounds. S. Afr. J. Bot. 2013, 88, 341–351. [Google Scholar] [CrossRef] [Green Version]
  24. Singh, H.; Mishra, A.; Mishra, A.K. The chemistry and pharmacology of Cleome genus: A review. Biomed. Pharmacother. 2018, 101, 37–48. [Google Scholar] [CrossRef]
  25. Bouriche, H.; Selloum, L.; Tigrine, C.; Boudoukha, C. Effect of Cleome arabica Leaf Extract on Rat Paw Edema and Human Neutrophil Migration. Pharm. Biol. 2003, 41, 10–15. [Google Scholar] [CrossRef]
  26. Tigrine, C.; Bulzomi, P.; Leone, S.; Bouriche, H.; Kameli, A.; Marino, M. Cleome arabica leaf extract has anticancer properties in human cancer cells. Pharm. Biol. 2013, 51, 1508–1514. [Google Scholar] [CrossRef] [Green Version]
  27. Cercato, L.M.; Araújo, J.M.D.; Oliveira, A.S.; Melo, A.J.O.; Lima, B.S.; dos Santos, E.W.P.; Neto, A.G.D.S.; de Albuquerque-Júnior, R.L.C.; Duarte, M.C.; Araujo, A.A.S.; et al. Reduced cutaneous inflammation associated with antioxidant action after topical application of the aqueous extract of Annona muricata leaves. Inflammopharmacology 2021, 29, 307–315. [Google Scholar] [CrossRef] [PubMed]
  28. Zammel, N.; Saeed, M.; Bouali, N.; Elkahoui, S.; Alam, J.M.; Rebai, T.; Kausar, M.A.; Adnan, M.; Siddiqui, A.J.; Badraoui, R. Antioxidant and Anti-Inflammatory Effects of Zingiber officinale roscoe and Allium subhirsutum: In Silico, Biochemical and Histological Study. Foods 2021, 10, 1383. [Google Scholar] [CrossRef]
  29. Moridi Farimani, M.; Nazarianpoor, E.; Rusaie, A.; Akhbari, M. Phytochemical constituents and biological activities of Cleome iberica DC. Nat. Prod. Res. 2017, 31, 1329–1332. [Google Scholar] [CrossRef]
  30. Costa, G.; Francisco, V.C.; Lopes, M.T.; Cruz, M.T.; Batista, M. Intracellular Signaling Pathways Modulated by Phenolic Compounds: Application for New Anti-Inflammatory Drugs Discovery. Curr. Med. Chem. 2012, 19, 2876–2900. [Google Scholar] [CrossRef]
  31. Fawole, O.A.; Ndhlala, A.R.; Amoo, S.O.; Finnie, J.F.; Van Staden, J. Anti-inflammatory and phytochemical properties of twelve medicinal plants used for treating gastro-intestinal ailments in South Africa. J. Ethnopharmacol 2009, 123, 237–243. [Google Scholar] [CrossRef] [PubMed]
  32. Soldado, D.; Bessa, R.J.B.; Jerónimo, E. Condensed Tannins as Antioxidants in Ruminants-Effectiveness and Action Mechanisms to Improve Animal Antioxidant Status and Oxidative Stability of Products. Animals 2021, 11, 3243. [Google Scholar] [CrossRef] [PubMed]
  33. Yuan, H.; Zhou, P.; Peng, Z.; Wang, C. Antioxidant and Antibacterial Activities of Dodecyl Tannin Derivative Linked with 1,2,3-Triazole. Chem. Biodivers. 2022, 19, e202100558. [Google Scholar] [CrossRef] [PubMed]
  34. Samout, N.; Bouzenna, H.; Ettaya, A.; Elfeki, A.; Hfaiedh, N. Antihypercholesterolemic effect of Cleome arabica L. on high cholesterol diet induced damage in rats. Excli J. 2015, 14, 791–800. [Google Scholar]
  35. Allagui, I.; Hcini, K.; Msalbi, D.; Saoudi, M.; El Feki, A.; Jordan, M.J.; Alwasel, S.; Harrath, A.H.; Allagui, M.S. Phytochemical screening, antioxidant properties, anti-apoptotic effects and molecular docking study of Tunisian cleome (Cleome arabica L.) fruits extract under optimized extraction conditions. Int. J. Food Prop. 2022, 25, 2107–2120. [Google Scholar] [CrossRef]
  36. Chen, X.; Ru, Y.; Chen, F.; Wang, X.; Zhao, X.; Ao, Q. FTIR spectroscopic characterization of soy proteins obtained through AOT reverse micelles. Food Hydrocoll. 2013, 31, 435–437. [Google Scholar] [CrossRef]
  37. Erdogan Orhan, I.; Küpeli Akkol, E.; Suntar, I.; Yesilada, E. Assessment of anticholinesterase and antioxidant properties of the extracts and (+)-catechin obtained from Arceuthobium oxycedri (D.C.) M. Bieb (dwarf mistletoe). S. Afr. J. Bot. 2019, 120, 309–312. [Google Scholar] [CrossRef]
  38. Greenwald, R.A. Animal models for evaluation of arthritis drugs. Methods Find. Exp. Clin. Pharmacol. 1991, 13, 75–83. [Google Scholar]
  39. Norma, A.; Claudia, S.E.G.; Tatiana, C.D.C.; Carlos, R.M.G.; Marsen, G.P.C.; Roberto, S.D.M.; Elisabeth, M. Anti-inflammatory and antinociceptive activity of field-growth plants and tissue culture of Cleome spinosa (Jacq.) in mice. J. Med. Plants Res. 2013, 7, 1043–1049. [Google Scholar]
  40. Bouriche, H.; Arnhold, J. Effect of Cleome arabica Leaf Extract Treated by Naringinase on Human Neutrophil Chemotaxis. Nat. Prod. Commun. 2010, 5, 1934578X1000500315. [Google Scholar] [CrossRef] [Green Version]
  41. de Visser, K.E.; Korets, L.V. Coussens LM. De novo carcinogenesis promoted by chronic inflammation is B lymphocyte dependent. Cancer Cell 2005, 7, 411–423. [Google Scholar] [CrossRef] [Green Version]
  42. Choudhary, M.; Kumar, V.; Gupta, P.K.; Singh, S. Anti-arthritic activity of Barleria prionitis Linn. leaves in acute and chronic models in Sprague Dawley rats. Bull. Fac. Pharm. Cairo Univ. 2014, 52, 199–209. [Google Scholar] [CrossRef] [Green Version]
  43. Rajaram, C.; Reddy, K.R.; Sekhar, K.B.C. Evaluation of anti-arthritic activity of Caesalpinia pulcherrima in freund’s complete adjuvant induced arthritic rat model. J. Young-Pharm. 2015, 7, 128–132. [Google Scholar] [CrossRef] [Green Version]
  44. Tian, Z.; Zhang, H.; Shang, C. Farrerol ameliorate adjuvant-induced ankle injury via alteration of PPAR-γ signal pathway. J. Food Biochem. 2021, 45, e13585. [Google Scholar] [CrossRef] [PubMed]
  45. John, N.A.A.; Shobana, G. Anti-inflammatory activity of Talinum fruticosum L. on formalin induced paw edema in albino rats. J. Appl. Pharm. Sci. 2012, 2, 123–127. [Google Scholar]
  46. Sato, A.; Nakashima, H.; Nakashima, M.; Ikarashi, M.; Nishiyama, K.; Kinoshita, M.; Seki, S. Involvement of the TNF and FasL Produced by CD11b Kupffer Cells/Macrophages in CCl4-Induced Acute Hepatic Injury. PLoS ONE 2014, 9, e92515. [Google Scholar] [CrossRef] [Green Version]
  47. Mohammadi, S.; Karimzadeh Bardei, L.; Hojati, V.; Ghorbani, A.; Nabiuni, M. Anti-Inflammatory Effects of Curcumin on Insulin Resistance Index, Levels of Interleukin-6, C-Reactive Protein, and Liver Histology in Polycystic Ovary Syndrome-Induced Rats. Cell J. 2017, 19, 425–433. [Google Scholar]
  48. Zhou, P.; Li, Q.; Su, S.; Dong, W.; Zong, S.; Ma, Q.; Yang, X.; Zuo, D.; Zheng, S.; Meng, X.; et al. Interleukin 37 Suppresses M1 Macrophage Polarization Through Inhibition of the Notch1 and Nuclear Factor Kappa B Pathways. Front. Cell Dev. Biol. 2020, 8, 56. [Google Scholar] [CrossRef]
  49. Ceciliani, F.; Giordano, A.; Spagnolo, V. The Systemic Reaction During Inflammation: The Acute-Phase Proteins. Protein Pept. Lett. 2002, 9, 211–223. [Google Scholar] [CrossRef]
  50. Sproston, N.R.; Ashworth, J.J. Role of C-Reactive Protein at Sites of Inflammation and Infection. Front. Immunol. 2018, 9, 754. [Google Scholar] [CrossRef] [Green Version]
  51. Fenkci, V.; Fenkci, S.; Yilmazer, M.; Serteser, M. Decreased total antioxidant status and increased oxidative stress in women with polycystic ovary syndrome may contribute to the risk of cardiovascular disease. Fertil. Steril. 2003, 80, 123–127. [Google Scholar] [CrossRef]
  52. Deligeoroglou, E.; Vrachnis, N.; Athanasopoulos, N.; Iliodromiti, Z.; Sifakis, S.; Siristatidis, C.; Creatsas, G.; Iliodromiti, S. Mediators of chronic inflammation in polycystic ovarian syndrome. Gynecol. Endocrinol. 2012, 28, 974–978. [Google Scholar] [CrossRef] [PubMed]
  53. Fatima, Q.; Amin, S.; Kawa, I.A.; Jeelani, H.; Manzoor, S.; Rizvi, S.M.; Rashid, F. Evaluation of antioxidant defense markers in relation to hormonal and insulin parameters in women with polycystic ovary syndrome (PCOS): A case-control study. Diabetes Metab. Syndr. Clin. Res. Rev. 2019, 13, 1957–1961. [Google Scholar] [CrossRef] [PubMed]
  54. Zhang, R.; Liu, H.; Bai, H.; Zhang, Y.; Liu, Q.; Guan, L.; Fan, P. Oxidative stress status in Chinese women with different clinical phenotypes of polycystic ovary syndrome. Clin. Endocrinol. 2017, 86, 88–96. [Google Scholar] [CrossRef] [PubMed]
  55. Drishya, S.; Dhanisha, S.S.; Guruvayoorappan, C. Anti-Inflammatory Potential Exhibited by Amomum subulatum Fruits Mitigates Experimentally Induced Acute and Chronic Inflammation in Mice: Evaluation of Antioxidant Parameters, Pro-Inflammatory Mediators and HO-1 Pathway. J. Am. Coll. Nutr. 2021, 40, 551–561. [Google Scholar] [CrossRef] [PubMed]
  56. Choi, Y.J.; Kang, J.S.; Park, J.H.Y.; Lee, Y.J.; Choi, J.S.; Kang, Y.H. Polyphenolic Flavonoids Differ in Their Antiapoptotic Efficacy in Hydrogen Peroxide–Treated Human Vascular Endothelial Cells. J. Nutr. 2003, 133, 985–991. [Google Scholar] [CrossRef] [PubMed]
  57. Rice-evans, C.A.; Miller, N.J.; Bolwell, P.G.; Bramley, P.M.; Pridham, J.B. The Relative Antioxidant Activities of Plant-Derived Polyphenolic Flavonoids. Free. Radic. Res. 1995, 22, 375–383. [Google Scholar] [CrossRef]
  58. Cin, A.N. Identifying Characteristic Properties and Antioxidant Effect of Quercetin Loaded Titanium Dioxide Nanoparticles. Ph.D. Thesis, Sabancı University, Tuzla, Turkey, 2021. [Google Scholar]
  59. Salganik, R.I. The Benefits and Hazards of Antioxidants: Controlling Apoptosis and Other Protective Mechanisms in Cancer Patients and the Human Population. J. Am. Coll. Nutr. 2013, 20, 464S–472S. [Google Scholar] [CrossRef]
  60. Yasmen, N.; Aziz, M.A.; Tajmim, A.; Akter, M.I.; Hazra, A.K.; Rahman, S.M.M. Analgesic and Anti-Inflammatory Activities of Diethyl Ether and n-Hexane Extract of Polyalthia suberosa Leaves. Evid.-Based Complement. Altern. Med. 2018, 2018, e5617234. [Google Scholar] [CrossRef] [Green Version]
  61. Eltom, S.; Abdellatif, A.; Maswadeh, H.; Al-Omar, M.; Abdel-Hafez, A.; Mohammed, H.; Agabein, E.; Alqasoomi, I.; Alrashidi, S.; Sajid, M.; et al. The Anti-Inflammatory Effect of a γ-Lactone Isolated from Ostrich Oil of Struthio camelus (Ratite) and Its Formulated Nano-Emulsion in Formalin-Induced Paw Edema. Molecules 2021, 26, 3701. [Google Scholar] [CrossRef]
  62. Kim, H.-D.; Cho, K.-H.; Lee, B.-W.; Kwon, Y.-S.; Lee, H.-S.; Choi, S.-H.; Ku, S.-K. Effects of Magnetic Infrared Laser Irradiation on Formalin-Induced Chronic Paw Inflammation of Mice. J. Phys. Ther. Sci. 2010, 22, 395–404. [Google Scholar] [CrossRef] [Green Version]
  63. Ahmad, N.S.; Waheed, A.; Farman, M.; Qayyum, A. Analgesic and anti-inflammatory effects of Pistacia integerrima extracts in mice. J. Ethnopharmacol. 2010, 129, 250–253. [Google Scholar] [CrossRef] [PubMed]
  64. Middleton, E.; Kandaswami, C.; Theoharides, T.C. The effects of plant flavonoids on mammalian cells: Implications for inflammation, heart disease, and cancer. Pharmacol. Rev. 2000, 52, 673–751. [Google Scholar]
  65. Malik, A.; Arooj, M.; Butt, T.T.; Zahid, S.; Zahid, F.; Jafar, T.H.; Waquar, S.; Gan, S.H.; Ahmad, S.; Mirza, M.U. In silico and in vivo characterization of cabralealactone, solasodin and salvadorin in a rat model: Potential anti-inflammatory agents. Drug Des. Devel. Ther. 2018, 12, 1431–1443. [Google Scholar] [CrossRef] [Green Version]
  66. Meena, A.; Yadav, D.K.; Srivastava, A.; Khan, F.; Chanda, D.; Chattopadhyay, S.K. In Silico Exploration of Anti-Inflammatory Activity of Natural Coumarinolignoids. Chem. Biol. Drug Des. 2011, 78, 567–579. [Google Scholar] [CrossRef]
  67. Zaki, A.A.; Al-Karmalawy, A.A.; El-Amier, Y.A.; Ashour, A. Molecular docking reveals the potential of Cleome amblyocarpa isolated compounds to inhibit COVID-19 virus main protease. New J. Chem. 2020, 44, 16752–16758. [Google Scholar] [CrossRef]
  68. Deng, L.; Liang, H.; Han, Y. Cyclooxygenase-2 and β-Catenin as Potential Diagnostic and Prognostic Markers in Endometrial Cancer. Front. Oncol. 2020, 10, 56. [Google Scholar] [CrossRef]
  69. Dowlati Beirami, A.; Hajimahdi, Z.; Zarghi, A. Docking-based 3D-QSAR (CoMFA, CoMFA-RG, CoMSIA) study on hydroquinoline and thiazinan-4-one derivatives as selective COX-2 inhibitors. J. Biomol. Struct. Dyn. 2019, 37, 2999–3006. [Google Scholar] [CrossRef]
  70. Singleton, V.L.; Rossi, J.A. Colorimetry of Total Phenolics with Phosphomolybdic-Phosphotungstic Acid Reagents. Am. J. Enol. Vitic. 1965, 16, 144–158. [Google Scholar]
  71. John, B.C.T.S.; George, S.; Reddy, V.R.K. Total phenolics and flavonoids in selected medicinal plants from Kerala. International J. Pharm. Pharm. Sci. 2014, 6, 406–408. [Google Scholar]
  72. Saad, H.; Charrier-El Bouhtoury, F.; Pizzi, A.; Rode, K.; Charrier, B.; Ayed, N. Characterization of pomegranate peels tannin extractives. Ind. Crops Prod. 2012, 40, 239–246. [Google Scholar] [CrossRef]
  73. Zheng, W.; Wang, S.Y. Antioxidant Activity and Phenolic Compounds in Selected Herbs. J. Agric. Food Chem. 2001, 49, 5165–5170. [Google Scholar] [CrossRef] [PubMed]
  74. Ordoñez, A.A.L.; Gomez, J.D.; Vattuone, M.A.; Lsla, M.I. Antioxidant activities of Sechium edule (Jacq.) Swartz extracts. Food Chem. 2006, 97, 452–458. [Google Scholar] [CrossRef]
  75. Oyaizu, M. Studies on Products of Browning Reaction. Jpn. J. Nutr. Diet. 1986, 44, 307–315. [Google Scholar] [CrossRef] [Green Version]
  76. Green, L.C.; Wagner, D.A.; Glogowski, J.; Skipper, P.L.; Wishnok, J.S.; Tannenbaum, S.R. Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. Anal. Biochem. 1982, 126, 131–138. [Google Scholar] [CrossRef]
  77. Seddighfar, M.; Mirghazanfari, S.M.; Dadpay, M. Analgesic and anti-inflammatory properties of hydroalcoholic extracts of Malva sylvestris, Carum carvi or Medicago sativa, and their combination in a rat model. J. Integr. Med. 2020, 18, 181–188. [Google Scholar] [CrossRef]
  78. Al-Hejjaj, W.K.G.; Numan, I.T.; Al-Sa’ad, R.Z.; Hussain, S.A. Anti-inflammatory activity of telmisartan in rat models of experimentally-induced chronic inflammation: Comparative study with dexamethasone. Saudi Pharm. J. 2011, 19, 29–34. [Google Scholar] [CrossRef] [Green Version]
  79. Morse, L.R.; Stolzmann, K.; Nguyen, H.P.; Jain, N.B.; Zayac, C.; Gagnon, D.R.; Tun, C.G.; Garshick, E. Association Between Mobility Mode and C-Reactive Protein Levels in Men With Chronic Spinal Cord Injury. Arch. Phys. Med. Rehabil. 2008, 89, 726–731. [Google Scholar] [CrossRef] [Green Version]
  80. Oh, L. Protein measurement with the folin phenol reagent. J. Biol. Chem. 1951, 193, 265–275. [Google Scholar]
  81. Fraga, C.G.; Leibovitz, B.E.; Tappel, A.L. Lipid peroxidation measured as thiobarbituric acid-reactive substances in tissue slices: Characterization and comparison with homogenates and microsomes. Free. Radic. Biol. Med. 1988, 4, 155–161. [Google Scholar] [CrossRef]
  82. Witko-Sarsat, V.; Friedlander, M.; Capeillère-Blandin, C.; Nguyen-Khoa, T.; Nguyen, A.T.; Zingraff, J.; Jungers, P.; Descamps-Latscha, B. Advanced oxidation protein products as a novel marker of oxidative stress in uremia. Kidney Int. 1996, 49, 1304–1313. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  83. Beauchamp, C.; Fridovich, I. Superoxide dismutase: Improved assays and an assay applicable to acrylamide gels. Anal. Biochem. 1971, 44, 276–287. [Google Scholar] [CrossRef] [PubMed]
  84. Flohé, L.; Günzler, W.A. Assays of glutathione peroxidase. In Methods in Enzymology; Academic Press: Cambridge, MA, USA, 1984; Volume 105, pp. 114–120. [Google Scholar]
  85. Jollow, D.J.; Thorgeirsson, S.S.; Potter, W.Z.; Hashimoto, M.; Mitchell, J.R. Acetaminophen-Induced Hepatic Necrosis. Pharmacology 1974, 12, 251–271. [Google Scholar] [CrossRef] [PubMed]
  86. Trott, O.; Olson, A.J. AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J. Comput. Chem. 2010, 31, 455–461. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  87. Wang, J.L.; Limburg, D.; Graneto, M.J.; Springer, J.; Hamper, J.R.B.; Liao, S.; Pawlitz, J.L.; Kurumbail, R.G.; Maziasz, T.; Talley, J.J.; et al. The novel benzopyran class of selective cyclooxygenase-2 inhibitors. Part 2: The second clinical candidate having a shorter and favorable human half-life. Bioorg. Med. Chem. Lett. 2010, 20, 7159–7163. [Google Scholar] [CrossRef]
Molecules 28 00026 g001 550
Figure 1. The evolution of paw edema size (mm) in control and treated groups: Control (non-treated rats): received injection with isotonic saline solution (NaCl, 0.9%); FOR: rats inflamed by formalin (2%); FOR+CA and FOR+INDO: rats inflamed by formalin and treated with CA, or indomethacin, respectively.
Figure 1. The evolution of paw edema size (mm) in control and treated groups: Control (non-treated rats): received injection with isotonic saline solution (NaCl, 0.9%); FOR: rats inflamed by formalin (2%); FOR+CA and FOR+INDO: rats inflamed by formalin and treated with CA, or indomethacin, respectively.
Molecules 28 00026 g001
Molecules 28 00026 g002 550
Figure 2. Hemogram parameters of experimental groups. * p < 0.05, ** p < 0.01 vs. control group; @ p < 0.05, @@ p <0.01, @@@ p < 0.001 vs. FOR group.
Figure 2. Hemogram parameters of experimental groups. * p < 0.05, ** p < 0.01 vs. control group; @ p < 0.05, @@ p <0.01, @@@ p < 0.001 vs. FOR group.
Molecules 28 00026 g002
Molecules 28 00026 g003 550
Figure 3. CRP and proinflammatory cytokines levels of experimental groups ** p < 0.05, *** p < 0.001 vs. control group; @ p < 0.05, @@@ p < 0.01, @@ p < 0.01 vs. FOR group; ++ p < 0.01 vs. FOR+CA group.
Figure 3. CRP and proinflammatory cytokines levels of experimental groups ** p < 0.05, *** p < 0.001 vs. control group; @ p < 0.05, @@@ p < 0.01, @@ p < 0.01 vs. FOR group; ++ p < 0.01 vs. FOR+CA group.
Molecules 28 00026 g003
Molecules 28 00026 g004 550
Figure 4. Photomicrographs of paw tissues from the studied groups. The control rats treated with physiological saline (NaCl, 0.9%) showed normal histological structure of both epidermis and dermis; FOR group received formalin 2% showed cumulative edema with massive infiltration of inflammatory cells and paw edema; FOR+CA and FOR+INDO groups treated with CA and INDO, respectively, showing very weak inflammatory reaction once compared with FOR group. Ep: epidermis, Der: dermis: inflammatory cells infiltration; edema.
Figure 4. Photomicrographs of paw tissues from the studied groups. The control rats treated with physiological saline (NaCl, 0.9%) showed normal histological structure of both epidermis and dermis; FOR group received formalin 2% showed cumulative edema with massive infiltration of inflammatory cells and paw edema; FOR+CA and FOR+INDO groups treated with CA and INDO, respectively, showing very weak inflammatory reaction once compared with FOR group. Ep: epidermis, Der: dermis: inflammatory cells infiltration; edema.
Molecules 28 00026 g004
Molecules 28 00026 g005 550
Figure 5. The representation of the 3D structure of «Catechin» with the best docking scores, bounded to the pocket region of COX-2. Micrographs of the pocket region with hydrogen bond (A) and hydrophobicity illustrations (A′) and the corresponding 2D diagram of interactions (B).
Figure 5. The representation of the 3D structure of «Catechin» with the best docking scores, bounded to the pocket region of COX-2. Micrographs of the pocket region with hydrogen bond (A) and hydrophobicity illustrations (A′) and the corresponding 2D diagram of interactions (B).
Molecules 28 00026 g005
Molecules 28 00026 g006 550
Figure 6. The representation of the 3D structure of «Indomethacin» bounded to the pocket region of COX-2. Micrographs of the pocket region with hydrogen bond (A) and hydrophobicity illustrations (A′) and the corresponding 2D diagram of interactions (B).
Figure 6. The representation of the 3D structure of «Indomethacin» bounded to the pocket region of COX-2. Micrographs of the pocket region with hydrogen bond (A) and hydrophobicity illustrations (A′) and the corresponding 2D diagram of interactions (B).
Molecules 28 00026 g006
Table
Table 1. Total phenolic, flavonoid and tannins contents of Cleome fruits extract.
Table 1. Total phenolic, flavonoid and tannins contents of Cleome fruits extract.
ExtractTotal Phenolic Content
(mg GAE/g DW)		Total Flavonoids Content (mg QE/g DW)Total Tannins Content
(mg CatE/g DW)
Aqueous230.22 ± 7.0855.08 ± 1.2815.17 ± 0.47
The data represented the means ± ESM for three replicates.
Table
Table 2. Phenolic compounds identified in Cleome fruits extract by HPLC.
Table 2. Phenolic compounds identified in Cleome fruits extract by HPLC.
Phenolic CompoundsRT (min)Quantification (mg/g DW)Chemical Structure
Quercetin5.983.45Molecules 28 00026 i001
Cathechin13.785.42Molecules 28 00026 i002
Kaempferol15.213.23Molecules 28 00026 i003
Rosmarinic acid21.780.12Molecules 28 00026 i004
Naringenin24.452.84Molecules 28 00026 i005
RT: retention time.
Table
Table 3. The antioxidant activity of Cleome fruits extract.
Table 3. The antioxidant activity of Cleome fruits extract.
ExtractDPPH IC50 (mg/mL)FRAP IC50 (mg/mL)NO· IC50 (mg/mL)
Aqueous3.346 ± 0.122.306 ± 0.140.023 ± 0.001
Vit C0.032 ± 0.0005 0.154 ± 0.0020.006 ± 0.001
The data represented the means ± ESM for three replicates.
Table
Table 4. The effects of Cleome fruits extract on paw thickness, % of inflammation and inhibition of paw edema in Formalin-induced chronic inflammation in rats.
Table 4. The effects of Cleome fruits extract on paw thickness, % of inflammation and inhibition of paw edema in Formalin-induced chronic inflammation in rats.
GroupsMean Paw Thickness (mm) at Zero TimeMean Paw Thickness (mm)
after 7 Days		Mean Increase in Paw Thickness (mm) after 7 DaysInflammation
(%)		Inhibition of Inflammation (%)
Control3.43 ± 0.073.5 ± 0.030.17 ± 0.012.04 NS-
FOR3.79 ± 0.289.77 ± 0.36 ***5.98 ± 0.26 ***157.78 ***-
FOR+CA3.67 ± 0.236.36 ± 0.43 ***2.69 ± 0.27 **73.29 ***55.01
FOR+INDO3.32 ± 0.116.6 ± 0.12 ***3.28 ± 0.09 **98.79 ***45.15
The data are expressed as mean ± SEM; n = 6 animals in each group; *** p < 0.001; ** p < 0.01 versus Control; NS: non-significant.
Table
Table 5. The oxidative stress markers, SOD and GPx antioxidant activities and GSH levels in paw tissue homogenate of control and treated rats.
Table 5. The oxidative stress markers, SOD and GPx antioxidant activities and GSH levels in paw tissue homogenate of control and treated rats.
GroupsControlFORFOR+CAFOR+INDO
MDA (nmol MDA/g of protein)11.5 ± 0.6314.61 ± 0.22 **9.76 ± 0.18 @@@11.56 ± 0.07
AOPP (µmol/mg of protein)1.2 ± 0.031.44 ± 0.02 ***1.01 ± 0.007 **@@@0.97 ± 0.007 ***
SOD (U/mg of protein)1.9 ± 0.091.16 ± 0.006 **1.74 ± 1.74 @@1.49 ± 0.003 *
GPx (µmol of GSH/mg of protein/min)3.29 ± 0.130.75 ± 0.04 ***3.11 ± 0.19 @@@2.95 ± 0.2
GSH (µmol GSH/mg of protein)1.19 ± 0.030.52 ± 0.002 ***1.02 ± 0.002 ***@@@1.05 ± 0.008 ***
The data are expressed as mean ± SEM; n = 6 animals in each group; *** difference significative compared to control (p < 0.001); * p < 0.05, ** p < 0.01, *** p < 0.001 vs. control group; @@ p < 0.01, @@@ p < 0.001 vs. FOR group.
Table
Table 6. The ligands and COX-2 interactions: binding affinity, number of conventional hydrogen bonds and interacting amino acid residues.
Table 6. The ligands and COX-2 interactions: binding affinity, number of conventional hydrogen bonds and interacting amino acid residues.
LigandBinding Affinity (kcal/mol)Intermolecular Interactions
Conventional Hydrogen BondsInteracting Amino Acid Residues
Quercetin (C)−6.53Val102, Arg106 *, Val335, Leu338, Tyr341 *, Leu345, Tyr371 *, Ala513, Leu517
Catechin (C)−9.86His75 *, Gln178 *, Val335 *, Leu338 *, Ser339 *, Trp373, Val509, Ser516 *
Kaempferol (C)−9.42Val335, Leu338, Tyr341 *, Tyr371 *, Val509, Ala513,
Rosmarinicacid (C)−8.05Arg106 *, Leu338 *, Tyr341 *, Phe504, Met508 *, Val509, Gly512, Ser516 *
Naringenin (C)−7.52Val335, Leu338, Tyr341, Tyr371 *, Val509, Gly512, Ala513, Ser516 *
Indomethacin (R)−5.42Arg106 *, Val335, Leu338, Tyr341 *, Phe367, Tyr371, Trp373, Val509,
Ala513, Ser516
(C): Compound of the extract, (R): Reference, drug, *: Amino acid residue involved in H-bond formation.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Allagui, I.; Horchani, M.; Zammel, N.; Jalouli, M.; Elfeki, A.; Kallel, C.; Mansour, L.; Alwasel, S.; Harrath, A.H.; Jannet, H.B.; et al. Phytochemical Characterization, Antioxidant and Anti-Inflammatory Effects of Cleome arabica L. Fruits Extract against Formalin Induced Chronic Inflammation in Female Wistar Rat: Biochemical, Histological, and In Silico Studies. Molecules 2023, 28, 26. https://doi.org/10.3390/molecules28010026

AMA Style

Allagui I, Horchani M, Zammel N, Jalouli M, Elfeki A, Kallel C, Mansour L, Alwasel S, Harrath AH, Jannet HB, et al. Phytochemical Characterization, Antioxidant and Anti-Inflammatory Effects of Cleome arabica L. Fruits Extract against Formalin Induced Chronic Inflammation in Female Wistar Rat: Biochemical, Histological, and In Silico Studies. Molecules. 2023; 28(1):26. https://doi.org/10.3390/molecules28010026

Chicago/Turabian Style

Allagui, Ikram, Mabrouk Horchani, Nourhene Zammel, Maroua Jalouli, Abdelfatteh Elfeki, Choumous Kallel, Lamjed Mansour, Salah Alwasel, Abdel Halim Harrath, Hichem Ben Jannet, and et al. 2023. "Phytochemical Characterization, Antioxidant and Anti-Inflammatory Effects of Cleome arabica L. Fruits Extract against Formalin Induced Chronic Inflammation in Female Wistar Rat: Biochemical, Histological, and In Silico Studies" Molecules 28, no. 1: 26. https://doi.org/10.3390/molecules28010026

APA Style

Allagui, I., Horchani, M., Zammel, N., Jalouli, M., Elfeki, A., Kallel, C., Mansour, L., Alwasel, S., Harrath, A. H., Jannet, H. B., Salah Allagui, M., & Hcini, K. (2023). Phytochemical Characterization, Antioxidant and Anti-Inflammatory Effects of Cleome arabica L. Fruits Extract against Formalin Induced Chronic Inflammation in Female Wistar Rat: Biochemical, Histological, and In Silico Studies. Molecules, 28(1), 26. https://doi.org/10.3390/molecules28010026

Article Metrics

Back to TopTop